We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 354

Biotech secures $7.2 million for cancer research

  • Shook Hardy & Bacon LLP
  • -
  • Singapore, USA
  • -
  • March 21 2013

Clearbridge BioMedics, a Singapore-based company that develops medical devices for cancer research and diagnostics, has announced a new series B

Illinois industry groups sign memorandum of cooperation with cChinese counterpart

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 7 2011

According to Illinois Governor Pat Quinn (D), the Illinois Science & Technology Coalition and iBIO, a state-based life-sciences industry association, have entered a memorandum of understanding with the Shanghai Bio Pharmaceutics Association

Biopharma co. seeks $90 million for tainted raw material from China

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 3 2012

A biopharmaceutical company has sued companies in its supply chain, alleging they were negligent or vicariously liable for obtaining from China a raw material, contaminated with beef broth and avian products, for use in the creation of a bacterial master cell bank for the production of a biologic drug that will be used in patients with acute spinal cord injury

FDA issues guidance on acceptance of foreign clinical studies not conducted under IND

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 15 2012

The Food and Drug Administration (FDA) has issued guidance titled “Guidance for Industry and FDA Staff: FDA Acceptance of Foreign Clinical Studies Not Conducted Under an IND, Frequently Asked Questions.”

Series B funding round brings $12 million to expand clinical diagnostics products

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 15 2012

Advanced Cell Dynamics, Inc. has reportedly completed a $12-million Series B equity financing round that will support the commercial expansion of the company’s RNAscope-based products and services

FTC reports “pay-for-delay” deal trend continuing

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 3 2011

The Federal Trade Commission (FTC) has found that the ongoing trend of drug companies settling claims filed by rival generic manufacturers with “pay-for-delay” deals is proceeding unabated

Dialysis equipment maker sues component part supplier for indemnification

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 17 2011

A company that makes dialysis equipment for use in clinics and by patients in their homes has filed a complaint in federal court against a company that supplied a component part which allegedly contained a defect that led to a recall and caused injuries and at least one death

U.S. Senators propose subjecting compounded drugs to federal regulation

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

Bipartisan Senate health committee leaders have released draft legislation that would give the Food and Drug Administration (FDA) greater oversight

Venture capitalists are returning to life-sciences investing

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 3 2012

Reuters reports that a number of global venture firms have renewed their interest in the life sciences and health-care sectors, motivated by big acquisitions, U.S. laws speeding up certain drug approval processes and new products that have broadened the life-sciences definition

Adequacy of generic drug warnings on U.S. Supreme Court agenda

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 7 2011

The U.S. Supreme Court is considering whether a generic drug maker can be held liable under state law for failing to include on its drug label safety information not yet used by name brand manufacturers or required by the Food and Drug Administration (FDA